A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RP-HPLC / reversed-phase HPLC

[Related PubMed/MEDLINE]
Total Number of Papers: 138
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RP-HPLC  (>> Co-occurring Abbreviation)
Long Form:   reversed-phase HPLC
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A Pipeline towards the Biochemical Characterization of the Arabidopsis GT14 Family. AGP, beta-1,3-Gal5, beta-1,6-Gal4, Gal-NBD, GlcA-T, GTs, MS
2021 Development and Validation of a Stability-Indicating Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) Method for Identification, Assay, and Estimation of Related Substances of Ivermectin Drug Substance. ACN
2021 Isocratic high-performance liquid chromatography (HPLC) for simultaneous quantification of curcumin and piperine in a microparticle formulation containing Curcuma longa and Piper nigrum. HPLC, ICH, LOD, Rs, RSD
2021 Reverse Phase-high-performance Liquid Chromatography (RP-HPLC) Analysis of Globin Chains from Human Erythroid Cells. ACN, BFU-E, CE, CE-HPLC, CEA, Hb, HSPCs, IEF, RBCs, SCD, TFA
2021 Unequivocal Identification of Aspartic Acid and isoAspartic Acid by MALDI-TOF/TOF: From Peptide Standards to a Therapeutic Antibody. Asp, CDR, CQA, isoAsp, mAbs
2020 An efficient method for recombinant production of human alpha synuclein in Escherichia coli using thioredoxin as a fusion partner. CD, E. coli, ESI, hAS, TEM, TEV, ThT, Trx
2020 Development and evaluation of new methods for protein quantification in dissolving microneedles formulations. c-BCA, DMNs, MBCA, OVA
2020 Partial Purification and Characterization of Bioactive Peptides from Cooked New Zealand Green-Lipped Mussel (Perna canaliculus) Protein Hydrolyzates. ACE, MW
2020 Pharmacokinetic profile of diosgenin and trigonelline following intravenous and oral administration of fenugreek seed extract and pure compound in rabbit. DI, TRG
10  2020 Structure and Function of Mung Bean Protein-Derived Iron-Binding Antioxidant Peptides. AEC, EC50, MBPH
11  2019 A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry. HYNIC, LC-MS, SPECT, Tc-99m, TCO, Tz
12  2019 Monitoring and exposure assessment of nitrate intake via fruits and vegetables in high and low risk areas for gastric cancer. CDI, FFQ, GC, HRA, LRA
13  2018 Characterization and analytical development for amphiphilic poly(gamma-glutamic acid) as raw material of nanoparticle adjuvants. gamma-PGA-Phe, MALS, MW, NPs, Phe, RI, SEC
14  2018 Development of a Method for Simultaneous Determination of Two Stilbenes and Four Anthraquinones from Polygonum Cuspidatum by RP-HPLC. ---
15  2018 Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A. MLC, PDE2A, PET
16  2018 Isolation and Structural Characterization of Antioxidant Peptides from Degreased Apricot Seed Kernels. ASKH
17  2018 Reversed phase HPLC for strontium ranelate: Method development and validation applying experimental design. ---
18  2017 Determination of Bortezomib in API Samples Using HPLC: Assessment of Enantiomeric and Diastereomeric Impurities. API, BZB, ICH, LOD, LOQ, NP-HPLC, Rs, Tf
19  2017 Identification and Characterization of a Novel Antioxidant Peptide from Bovine Skim Milk Fermented by Lactococcus lactis SL6. HPLC
20  2017 Recombinant expression of Ixolaris, a Kunitz-type inhibitor from the tick salivary gland, for NMR studies. FVIIa, TF, TFPI
21  2016 A sensitive and practical RP-HPLC-FLD for determination of the low neuroactive amino acid levels in body fluids and its application in depression. AAs, BD, CSF, FLD, GABA, Glu, HPLC, MDD
22  2016 A simple and rapid RP-HPLC method for the simultaneous determination of piperacillin and tazobactam in human plasma. ---
23  2016 Enantioseparation of Citalopram by RP-HPLC, Using Sulfobutyl Ether-beta-Cyclodextrin as a Chiral Mobile Phase Additive. CIT, SBE-beta-CD
24  2016 Heterologous expression of five disulfide-bonded insecticidal spider peptides. DUM, IPTG
25  2016 Heterologous expression, protein folding and antibody recognition of a neurotoxin from the Mexican coral snake Micrurus laticorallis. nMlat1
26  2016 Physical-chemical and biological characterization of different preparations of equine chorionic gonadotropin. eCG
27  2016 The effects of hybridization on divergent venom phenotypes: Characterization of venom from Crotalus scutulatus scutulatusCrotalus oreganus helleri hybrids. ---
28  2015 Evaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa. CFS, FIC, MBC, MIC
29  2015 Surfactin from Bacillus subtilis displays an unexpected anti-Legionella activity. ---
30  2014 Changes of proteolysis and angiotensin-I converting enzyme-inhibitory activity in white-brined cheese as affected by adjunct culture and ripening temperature. ACE, urea-PAGE
31  2014 Development and application of a reversed-phase high-performance liquid chromatographic method for quantitation and characterization of a Chikungunya virus-like particle vaccine. HPLC, LC-MS, MALDI-TOF, MS, SDS-PAGE, VLP
32  2014 Hydrogen sulfide measurement using sulfide dibimane: critical evaluation with electrospray ion trap mass spectrometry. CID, ESI/MS, SDB, SRM
33  2014 Improvements in phenotype studies of hemoglobin disorders brought by advances in reversed-phase chromatography of globin chains. Hb
34  2014 Isolation and characterization of a protease inhibitor from Acacia karroo with a common combining loop and overlapping binding sites for chymotrypsin and trypsin. ---
35  2013 Characterization of a site-specific PEGylated analog of exendin-4 and determination of the PEGylation site. AAA, Tricine-SDS-PAGE
36  2012 A study of the thermodynamics of retention of block (co)oligomers using high-performance liquid chromatography/mass spectrometry. co, co
37  2012 Development and calibration of a standard for the protein content of granulocyte colony-stimulating factor products. G-CSF
38  2012 Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations. DSC, IR, MS, SE-HPLC
39  2012 Increased hemagglutinin content in a reassortant 2009 pandemic H1N1 influenza virus with chimeric neuraminidase containing donor A/Puerto Rico/8/34 virus transmembrane and stalk domains. HA, NA, NP, PR8, TM
40  2012 Laboratory production of human prolactin from CHO cells adapted to serum-free suspension culture. CHO, hPRL, HPSEC
41  2012 Optimized preparation of celastrol-loaded polymeric nanomicelles using rotatable central composite design and response surface methodology. DLP, EE, RCCD, RSM, TEM
42  2012 [Analytical profile of 1-[3-(3-propoxyphenylcarbamoyloxy)-2-hydroxypropyl]-4-(3-trifluoromethylphenyl)piperazinium chloride]. ---
43  2012 [Analytical profile of mono[{3-[4-(2-ethoxyethoxy)-benzoyloxy]-2-hydroxypropyl}-tert-butylammonium] fumarate]. ---
44  2011 Comparison of preparative reversed phase liquid chromatography and countercurrent chromatography for the kilogram scale purification of crude spinetoram insecticide. HPCCC
45  2011 Development of an orthogonal method for mometasone furoate impurity analysis using supercritical fluid chromatography. SFC
46  2011 Expression, purification, and reconstitution of the transmembrane domain of the human amyloid precursor protein for NMR studies. AD, APP, TM
47  2011 Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays. HA, SRID
48  2011 [Analytical evaluation of mono[{3-[4-(2-etoxyetoxy)-benzoyloxy]-2-hydroxypropyl}-isopropylammonium]fumarate]. ---
49  2010 A stability-indicating reversed-phase high performance liquid chromatography method for simultaneous assay of two corticosteroids and estimation of their related compounds in a pharmaceutical injectable formulation. APIs
50  2010 Actinidin enhances protein digestion in the small intestine as assessed using an in vitro digestion model. ---
51  2010 Development and validation of a stability-indicating RP-HPLC method for simultaneous assay of betamethasone dipropionate, chlorocresol, and for the estimation of betamethasone dipropionate related compounds in a pharmaceutical cream and ointment. BD, LOD, LOQ
52  2010 Production of thymosin alpha1 via non-enzymatic acetylation of the recombinant precursor. ---
53  2010 Reversed-phase High Performance Liquid Chromatography of proteins. ---
54  2010 The major protein fraction of mouse milk revisited using proven proteomic tools. ---
55  2009 A systematic approach to the accurate quantification of selenium in serum selenoalbumin by HPLC-ICP-MS. AF-HPLC, GPx, SE-HPLC, SeAlb, SelP, SeMet, SSID
56  2009 Enrichment and analysis of Alzheimer's Abeta1-42 peptide in human plasma and whole blood. APP, SPE
57  2009 Protein-loaded PLGA microparticles engineered by flow focusing: physicochemical characterization and protein detection by reversed-phase HPLC. FF, GFP, PLGA
58  2008 Amino acid analysis. AAA, PTC-AAA
59  2008 Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels. LPS, NAC, PAMAM
60  2008 Electrochemical, HPLC and electrospray ionization mass spectroscopic analyses of peroxycitric acid coexisting with citric acid and hydrogen peroxide in aqueous solution. CA, CA, ESI-MS, HCC, PCA
61  2008 Enzymatic digestion of proteins in solution. MS
62  2008 Lipophilicity measurement of drugs by reversed phase HPLC over Wide pH range using an alkaline-resistant silica-based stationary phase, XBridge Shield RP(18). LSER
63  2008 Molecular identification of lyso-glycerophosphocholines as endogenous immunosuppressives in bovine and rat gonadal fluids. lyso-GPCs
64  2008 Preparative separation of cis- and trans-isomers of unsaturated fatty acid methyl esters contained in edible oils by reversed-phase high-performance liquid chromatography. FAMEs, GC
65  2008 Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli. EGF, rhEGF
66  2008 Stability indicating RP-HPLC method development and validation for oseltamivir API. API
67  2008 [Identification of the 987P protein receptors for enterotoxigenic Escherichia coli]. BBV, ETEC
68  2007 A multi-dimensional high performance liquid chromatographic method for fingerprinting polycyclic aromatic hydrocarbons and their alkyl-homologs in the heavy gas oil fraction of Alaskan North Slope crude. DAD, HPLC
69  2007 Comparative evaluation of high-performance liquid chromatography stationary phases used for the separation of peptides in terms of quantitative structure-retention relationships. HPLC, PCA, QSRR
70  2007 Determination of selectivity differences for basic compounds in gradient reverse phase high performance liquid chromatography under high pH conditions by partial least squares modelling. HPLC, PCA, PLS, QSRRs
71  2007 Determination of tryptophan oxidation of monoclonal antibody by reversed phase high performance liquid chromatography. SE-HPLC
72  2007 Identification of diadenosine triphosphate in Brugia malayi by reverse phase high performance liquid chromatography and MALDI mass spectrometry. HPLC
73  2007 Perfusion reversed-phase high-performance liquid chromatography/mass spectrometry analysis of intact soybean proteins for the characterization of soybean cultivars. ---
74  2007 The purification and characterization of alpha interferons and related cytokine receptors--a personal account. ---
75  2007 Uniform-sized molecularly imprinted polymer for metsulfuron-methyl by one-step swelling and polymerization method. 4-VPY, EDMA, MIP, MSM, SPE, SUs
76  2006 Development and validation of a RP-HPLC method for quantification of isoflavone aglycones in hydrolyzed soy dry extracts. DAD
77  2006 Influence of prosthetic radioiodination on the chemical and biological behavior of chemotactic peptides labeled at high specific activity. ---
78  2006 Purification of MINUS: A negative regulator of microtubule nucleation in a variety of organisms. MINUS, MT
79  2006 Structural and functional properties of Cr 5, a new Lys49 phospholipase A2 homologue isolated from the venom of the snake Calloselasma rhodostoma. i.c.v
80  2005 Determination of protamine peptides in insulin drug products using reversed phase high performance liquid chromatography. ---
81  2005 HPLC and tandem detection to monitor conformational properties of biopharmaceuticals. CD, HPLC, SEC
82  2005 Orthogonal method development using hydrophilic interaction chromatography and reversed-phase high-performance liquid chromatography for the determination of pharmaceuticals and impurities. HILIC
83  2005 Quantitation of adenovirus type 5 empty capsids. pVIII
84  2005 Simultaneous quantification of stavudine, lamivudine and nevirapine by UV spectroscopy, reverse phase HPLC and HPTLC in tablets. LV, NV, SV
85  2005 The methods for determining the purity and in vitro or in vivo activity of recombinant human endostatin. BCEs, GF-HPLC, HPLC, HUVECs, hVEGF, rh-endostatin
86  2005 Two-step chromatographic purification of recombinant human thyrotrophin and its immunological, biological, physico-chemical and mass spectral characterization. HPLC
87  2004 BDNF-overexpression regulates the reactivity of small pulmonary arteries to neurokinin A. BDNF, JNC, NKA
88  2004 UV spectroscopy and reverse-phase HPLC as novel methods to determine Capreomycin of liposomal fomulations. NP-HPLC
89  2003 A new type of chemically bonded phase for reversed-phase HPLC. FTIR
90  2003 Purification of soluble human epidermal growth factor (hEGF) from recombinant Escherichia coli culture broth by using expanded-bed adsorption chromatography. EBA, hEGF
91  2003 Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties. BBN, ES-MS, GRP, GRPR, SPPS
92  2003 Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells. BBN, ES-MS, GRP, GRPR, SPPS
93  2003 Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies. BBN, GRP, GRPR, SPPS
94  2003 Selective roles for the PC2 processing enzyme in the regulation of peptide neurotransmitter levels in brain and peripheral neuroendocrine tissues of PC2 deficient mice. PC2
95  2002 A simple preparation of stationary phase of alkylamide reversed-phase liquid chromatograph for the separation of basic substances. FTIR
96  2002 Guanosine diphosphate-4-keto-6-deoxy-d-mannose reductase in the pathway for the synthesis of GDP-6-deoxy-d-talose in Actinobacillus actinomycetemcomitans. GDP
97  2001 Enzymatic characterization of a novel phospholipase A2 from Crotalus durissus cascavella rattlesnake (Maracamboia) venom. ---
98  2001 Enzymatic characterization of a novel phospholipase A2 from Crotalus durissus cascavella rattlesnake (Maracamboia) venom. HPLC
99  2001 Molecular forms of human brain natriuretic peptide in plasma. BNP, MW
100  2001 Year-long validation study and reference values for urinary amino acids using a reversed-phase HPLC method. ---